胃癌肿瘤标志物CDX2研究与应用进展  

The Status and Progress of CDX2 in Judging Gastric Cancer

作　　者：姜杰 曲灿华[1] 王汉卿 马雷[1] 王芳[1] 孙玉鸿[1] Jiang Jie;Qu Canhua;Wang Hanqing;Ma Lei;Wang Fang;Sun Yuhong(Jiamusi University,Jiamusi 154007,China)

机构地区：[1]佳木斯大学,黑龙江佳木斯154007

出　　处：《广东化工》2021年第3期148-148,164,共2页Guangdong Chemical Industry

摘　　要：胃癌是最常见的肿瘤之一,胃癌的早期症状不明显,出现严重病情时,已是晚期病变。随着分子标志物的研究和发展,并将其应用到恶性肿瘤的诊断,具有很高的临床应用价值。因此针对CDX2在胃癌诊断中的现状及进展做简要综述。Gastric cancer is one of the most common tumors.The early symptoms of gastric cancer are not obvious.When a serious condition appears,it is already an advanced disease.With the research and development of molecular markers and their application to the diagnosis of malignant tumors,they have high clinical application value.Therefore,a brief review of the current status and progress of CDX2 in the diagnosis of gastric cancer is given.

关 键 词：胃癌 CDX2 

分 类 号：TQ[化学工程]